hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06307353, orgStudyIdInfo id: Soh_Med_23_12_05MS, briefTitle: Trends of Contraception Methods in Urban Medical Center in el_Balyana, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03-01, primaryCompletionDateStruct date: 2024-10-01, completionDateStruct date: 2025-03-01, studyFirstPostDateStruct date: 2024-03-12, lastUpdatePostDateStruct date: 2024-03-12, sponsorCollaboratorsModule leadSponsor name: Sohag University, class: OTHER, descriptionModule briefSummary: family planning is avital primary Health care intervention that saves lives of mothers and infants empowers women and support their choices regarding their health public life and additional education .In addition family planning is considered as a short term intervention to limit population growth and manage overpopulation problems.Globally the contraception prevalance rate an indicator for family planning programs continue to face challenges in developing countries., conditionsModule conditions: Contraception, designModule studyType: OBSERVATIONAL, designInfo observationalModel: OTHER, timePerspective: RETROSPECTIVE, enrollmentInfo count: 385, type: ESTIMATED, armsInterventionsModule interventions name: trends of contraception methods, outcomesModule primaryOutcomes measure: number of married women in child bearing period attending the El_Balyana Medical Center using contraception methods ., eligibilityModule sex: FEMALE, minimumAge: 15 Years, maximumAge: 49 Years, stdAges: CHILD, stdAges: ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06307327, orgStudyIdInfo id: NFEC-2024-098, briefTitle: Comparative Study of New Classification and Traditional Classification of Radioactive Oropharyngeal Mucositis, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-03, primaryCompletionDateStruct date: 2025-12, completionDateStruct date: 2026-12, studyFirstPostDateStruct date: 2024-03-12, lastUpdatePostDateStruct date: 2024-03-26, sponsorCollaboratorsModule leadSponsor name: Nanfang Hospital, Southern Medical University, class: OTHER, descriptionModule briefSummary: Radiation oropharyngeal mucositis is one of the most painful side effects of radiotherapy in patients with head and neck tumors. However, the traditional radioactive oropharyngeal mucositis grading system has the problem of poor evaluation consistency. To solve this problem, we innovatively classify radiation oropharyngeal mucositis into four types according to the four-stage histopathological changes of acute radiation injury: (1) congestive; (2) Scattered erosion type; (3) Fusion erosion type; (4) Ulcer type. We intend to conduct a multicenter observational cohort study to compare the consistency of different physicians in the assessment of radiation oropharyngeal mucositis with new and traditional classifications, and to explore changes in blood markers of different types of oropharyngeal mucositis using clinical residual blood samples., conditionsModule conditions: Head and Neck Cancer, conditions: Radiation-Induced Mucositis, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 894, type: ESTIMATED, outcomesModule primaryOutcomes measure: Evaluation consistency, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Southern medical university, status: RECRUITING, city: Guangzhou, state: Guangdong, zip: 510515, country: China, contacts name: Jian Guan, M.D, role: CONTACT, phone: 86+13632102247, email: guanjian5461@163.com, geoPoint lat: 23.11667, lon: 113.25, locations facility: Huizhou Central People's Hospital, status: NOT_YET_RECRUITING, city: Huizhou, state: Guangdong, zip: 516000, country: China, contacts name: Yunming Tian, role: CONTACT, geoPoint lat: 23.11147, lon: 114.41523, locations facility: Jieyang people's hospital, status: NOT_YET_RECRUITING, city: Jieyang, state: Guangdong, zip: 522000, country: China, contacts name: Peibao Lai, role: CONTACT, phone: 86+15975196057, email: boa71@139.com, geoPoint lat: 23.5418, lon: 116.36581, locations facility: Meizhou People's Hospital, Meizhou Academy of Medical Sciences Meizhou, status: NOT_YET_RECRUITING, city: Meizhou, state: Guangdong, zip: 514000, country: China, contacts name: Jianda Sun, role: CONTACT, geoPoint lat: 24.2886, lon: 116.11767, hasResults: False
protocolSection identificationModule nctId: NCT06307301, orgStudyIdInfo id: PRO00031998, briefTitle: Study in ALS With Abatacept & IL-2, statusModule overallStatus: ACTIVE_NOT_RECRUITING, startDateStruct date: 2021-10-28, primaryCompletionDateStruct date: 2024-10-17, completionDateStruct date: 2024-10-17, studyFirstPostDateStruct date: 2024-03-12, lastUpdatePostDateStruct date: 2024-04-16, sponsorCollaboratorsModule leadSponsor name: The Methodist Hospital Research Institute, class: OTHER, descriptionModule briefSummary: In Amyotrophic Lateral Sclerosis (ALS), the reduction of regulatory T-lymphocyte (Treg) numbers and suppressive function correlates with rapid disease progression. The investigator completed a phase 1 study of infusions of expanded autologous Tregs in combination with subcutaneous IL-2 injections in ALS patients, which showed enhancement of Treg numbers and suppressive function in vivo. The enhanced Treg suppressive function correlated strongly with slowing and stabilization of disease progression. Drugs that enhance endogenous Treg numbers and suppressive function may also stabilize disease in ALS. This phase 1 study aims to determine whether the combination therapy of subcutaneous IL-2 and abatacept (Orencia®) is safe and well-tolerated in 6 patients with ALS, and whether the therapy enhances Treg numbers and suppressive function in vivo., conditionsModule conditions: Amyotrophic Lateral Sclerosis, designModule studyType: INTERVENTIONAL, phases: PHASE1, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 5, type: ACTUAL, armsInterventionsModule interventions name: Abatacept Injection [Orencia] and Proleukin (aldesleukin), outcomesModule primaryOutcomes measure: To evaluate adverse events and laboratory abnormalities to assess the safety and tolerability of abatacept followed by Interleukin 2 (IL-2) administration in ALS patients, secondaryOutcomes measure: Change in Regulatory T cells (Tregs) numbers in the blood from baseline, secondaryOutcomes measure: Change in Regulatory T cells (Tregs) suppressive function in the blood from baseline, secondaryOutcomes measure: Changes in the level of cytokines secreted by PBMCs from baseline, otherOutcomes measure: Changes in Appel Amyotrophic Lateral Sclerosis rating scale ( AALS) slope, otherOutcomes measure: Changes in Amyotrophic Lateral Sclerosis functional rating scale-revised (ALSFRS-R) slope, otherOutcomes measure: Changes in forced vital capacity (FVC) and maximum inspiratory pressure (MIP) scores, otherOutcomes measure: Changes in maximum inspiratory pressure (MIP) scores, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Houston Methodist Research Institute, city: Houston, state: Texas, zip: 77030, country: United States, geoPoint lat: 29.76328, lon: -95.36327, hasResults: False
protocolSection identificationModule nctId: NCT06307288, orgStudyIdInfo id: 20240301-2, briefTitle: Efficacy and Safety of Tranilast Combined With Minocycline in the Treatment of Rosacea, statusModule overallStatus: ENROLLING_BY_INVITATION, startDateStruct date: 2023-10-16, primaryCompletionDateStruct date: 2024-06-01, completionDateStruct date: 2024-06-01, studyFirstPostDateStruct date: 2024-03-12, lastUpdatePostDateStruct date: 2024-03-12, sponsorCollaboratorsModule leadSponsor name: Second Affiliated Hospital of Xi'an Jiaotong University, class: OTHER, descriptionModule briefSummary: Rosacea is a chronic inflammatory skin disease with a complex pathogenesis involving multiple factors. Currently, the treatment of rosacea remains highly challenging. Mast cells, as key participants in the pathogenesis of rosacea, have been shown to alleviate rosacea symptoms with some topical, oral, and injectable mast cell stabilizers in recent years. Tranilast stabilizes mast cells and basophils by acting on their cell membranes and preventing their degranulation. Tranilast has been used in the treatment of various skin disease, such as hypertrophic scars and atopic dermatitis. Minocycline is a first-line treatment for rosacea, and low-dose minocycline treatment (50mg/day) is believed to have anti-inflammatory effects without antibacterial effects, thus minimizing the dysbiosis and bacterial resistance caused by antibiotic use. Therefore, this study aims to investigate the effectiveness and safety of combining mast cell stabilizer tranilast with low-dose minocycline treatment for rosacea, providing new treatment options and insights for rosacea patients., conditionsModule conditions: Rosacea, designModule studyType: INTERVENTIONAL, phases: PHASE4, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: SINGLE, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 45, type: ESTIMATED, armsInterventionsModule interventions name: minocycline, interventions name: tranilast, outcomesModule primaryOutcomes measure: lesion counts, primaryOutcomes measure: Clinician's Erythema Assessment score, primaryOutcomes measure: Global Flushing Severity Scale score, primaryOutcomes measure: Global Acne Grading System score, secondaryOutcomes measure: patient satisfaction evaluation, secondaryOutcomes measure: melanin index, secondaryOutcomes measure: erythema index, secondaryOutcomes measure: transepidermal water loss, secondaryOutcomes measure: Dermatology Life Quality Index score, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 60 Years, stdAges: ADULT, contactsLocationsModule locations facility: The Second Affiliated Hospital of Xi'an Jiaotong Universi, city: Xi'an, state: Shaanxi, zip: 710000, country: China, geoPoint lat: 34.25833, lon: 108.92861, hasResults: False
protocolSection identificationModule nctId: NCT06307275, orgStudyIdInfo id: 5170221, briefTitle: Intermittent Fasting on Body Fat and Quality of Life, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-03-11, primaryCompletionDateStruct date: 2024-12-31, completionDateStruct date: 2024-12-31, studyFirstPostDateStruct date: 2024-03-12, lastUpdatePostDateStruct date: 2024-04-12, sponsorCollaboratorsModule leadSponsor name: Loma Linda University, class: OTHER, descriptionModule briefSummary: The purpose of this investigator-initiated study to check the feasibility that intermittent fasting has on body fat loss and quality of life., conditionsModule conditions: Healthy, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NON_RANDOMIZED, interventionModel: CROSSOVER, primaryPurpose: OTHER, maskingInfo masking: NONE, enrollmentInfo count: 70, type: ESTIMATED, armsInterventionsModule interventions name: Fasting, interventions name: non fasting, outcomesModule primaryOutcomes measure: Body fat percentage, primaryOutcomes measure: Visceral fat, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 65 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Loma Linda University, status: RECRUITING, city: Loma Linda, state: California, zip: 92350, country: United States, contacts name: Gurinder Bains, PhD, role: CONTACT, phone: 909-558-4000, phoneExt: 87274, email: gbains@llu.edu, geoPoint lat: 34.04835, lon: -117.26115, hasResults: False
protocolSection identificationModule nctId: NCT06307262, orgStudyIdInfo id: EuroTR Registry, briefTitle: European Registry of Transcatheter Repair for Tricuspid Regurgitation, acronym: EuroTR, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-10-23, primaryCompletionDateStruct date: 2030-12-31, completionDateStruct date: 2030-12-31, studyFirstPostDateStruct date: 2024-03-12, lastUpdatePostDateStruct date: 2024-03-15, sponsorCollaboratorsModule leadSponsor name: LMU Klinikum, class: OTHER, descriptionModule briefSummary: To investigate clinical and survival outcomes following transcatheter tricuspid valve repair or replacement., conditionsModule conditions: Tricuspid Regurgitation, conditions: Valvular Heart Disease, conditions: Heart Failure, designModule studyType: OBSERVATIONAL, designInfo observationalModel: OTHER, timePerspective: OTHER, enrollmentInfo count: 3000, type: ESTIMATED, armsInterventionsModule interventions name: T-TEER, outcomesModule primaryOutcomes measure: All-cause mortality, secondaryOutcomes measure: Technical success, secondaryOutcomes measure: Procedural Safety, secondaryOutcomes measure: Heart Failure Biomarker, secondaryOutcomes measure: Dyspnea on exertion, secondaryOutcomes measure: Functional capacity, secondaryOutcomes measure: Right ventricular size, secondaryOutcomes measure: Right ventricular function, secondaryOutcomes measure: Tricuspid regurgitation reduction, secondaryOutcomes measure: Tricuspid valve stenosis, secondaryOutcomes measure: Pulmonary hypertension, secondaryOutcomes measure: Right heart congestion, secondaryOutcomes measure: Hospitalization for heart failure, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: LMU Klinikum, status: RECRUITING, city: Munich, state: Bavaria, zip: 81377, country: Germany, contacts name: Jörg Hausleiter, Prof. Dr., role: CONTACT, phone: +49 89 4400 72360, email: Joerg.Hausleiter@med.uni-muenchen.de, contacts name: Lukas Stolz, Dr., role: CONTACT, email: Lukas.Stolz@med.uni-muenchen.de, geoPoint lat: 48.13743, lon: 11.57549, hasResults: False
protocolSection identificationModule nctId: NCT06307236, orgStudyIdInfo id: E-41997688-050.99-105442, briefTitle: Dysmenorrhea of Emotional Freedom Techniques (EFT) and Its Effect on Perceived Stress Level, statusModule overallStatus: ENROLLING_BY_INVITATION, startDateStruct date: 2023-12-15, primaryCompletionDateStruct date: 2024-04-15, completionDateStruct date: 2024-04-15, studyFirstPostDateStruct date: 2024-03-12, lastUpdatePostDateStruct date: 2024-03-12, sponsorCollaboratorsModule leadSponsor name: Kutahya Health Sciences University, class: OTHER, descriptionModule briefSummary: The aim of the study is to determine the effect of EFT application on the level of dysmenorrhea and stress perception in women with dysmenorrhea. For this purpose, EFT will be applied to women with dysmenorrhea with high stress perception assigned to the experimental and control groups, and their stress perceptions and dysmenorrhea levels will be re-evaluated after the application. Perceived Stress Scale (PSS) and Visual Analog Scale (VAS) will be used in the research., conditionsModule conditions: Dysmenorrhea Primary, conditions: Stress, conditions: Emotional Freedom, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Randomized Controlled Study, primaryPurpose: SUPPORTIVE_CARE, maskingInfo masking: SINGLE, maskingDescription: Single Blinded, whoMasked: PARTICIPANT, enrollmentInfo count: 56, type: ESTIMATED, armsInterventionsModule interventions name: Emotional Freedom Techniques, outcomesModule primaryOutcomes measure: EFT application, primaryOutcomes measure: Control, eligibilityModule sex: FEMALE, minimumAge: 18 Years, maximumAge: 49 Years, stdAges: ADULT, contactsLocationsModule locations facility: Kütahya Health Science University, city: Kütahya, zip: 43000, country: Turkey, geoPoint lat: 39.42417, lon: 29.98333, hasResults: False
protocolSection identificationModule nctId: NCT06307223, orgStudyIdInfo id: 20240301, briefTitle: Efficacy and Safety of 30% Supramolecular Salicylic Acid Combined With Supramolecular Active Zinc in the Treatment of Malassezia Folliculitis, statusModule overallStatus: COMPLETED, startDateStruct date: 2022-06-07, primaryCompletionDateStruct date: 2023-09-20, completionDateStruct date: 2023-09-20, studyFirstPostDateStruct date: 2024-03-12, lastUpdatePostDateStruct date: 2024-03-12, sponsorCollaboratorsModule leadSponsor name: Second Affiliated Hospital of Xi'an Jiaotong University, class: OTHER, descriptionModule briefSummary: Malassezia folliculitis is a common dermatological disorder. While antifungal agents generally demonstrate efficacy in application, the prevalence of recurrence and drug resistance remains a common occurrence. Supramolecular salicylic acid represents a novel class of superficial chemical peel agents, exhibiting keratolytic, anti-inflammatory, and bacteriostatic properties. Zinc pyrithione has broad spectrum antibacterial, antifungal, and anti-inflammatory effects. In the present study, investigators evaluated the clinical efficacy of topical application of supramolecular salicylic acid in combination with zinc pyrithione for the treatment and prevention of Malassezia folliculitis recurrence. All data are recorded and compared after the end of the experiment. The enrolled patients received daily application of topical supramolecular active zinc anti-dandruff lotion, in conjunction with weekly application of 30% supramolecular salicylic acid, for a duration of 8 weeks. Lesion counts, Malassezia detection, clinical symptom scores, patient satisfaction, and side effects were recorded at each visit till the week 12., conditionsModule conditions: Malassezia Folliculitis, designModule studyType: INTERVENTIONAL, phases: PHASE4, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 21, type: ACTUAL, armsInterventionsModule interventions name: 30% supramolecular salicylic acid, interventions name: supramolecular active zinc, outcomesModule primaryOutcomes measure: lesion counts, primaryOutcomes measure: The reduction rate of lesion counts, primaryOutcomes measure: Clinical efficacy, secondaryOutcomes measure: Clinical symptoms scores, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 65 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: The Second Affiliated Hospital of Xi'an Jiaotong University, city: Xi'an, state: Shaanxi, zip: 710000, country: China, geoPoint lat: 34.25833, lon: 108.92861, hasResults: False
protocolSection identificationModule nctId: NCT06307210, orgStudyIdInfo id: coreset_2020_2022, briefTitle: Is Inpatient Rehabilitation Effective for Very Old Patients?, statusModule overallStatus: COMPLETED, startDateStruct date: 2020-01-01, primaryCompletionDateStruct date: 2022-12-31, completionDateStruct date: 2023-01-01, studyFirstPostDateStruct date: 2024-03-12, lastUpdatePostDateStruct date: 2024-03-12, sponsorCollaboratorsModule leadSponsor name: Klinik Valens, class: OTHER, descriptionModule briefSummary: The goal of this retrospective longitudinal observational study is to compare the effects of physical and mental performance as well as quality of life in patients with neurological and musculoskeletal disorders.The main question it aims to answer is: Do very old patients benefit in a similar way from inpatient rehabilitation like younger patients? Data from about 2000 patients will be retrospectively analyzed. Functional Independence Measurement (FIM), Timed Up and Go Test (TUG), EuroQol 5 Dimensions (EQ-5D) and Patient Reported Outcomes Measurement Information System (PROMIS) were recorded on admission and discharge.Researchers will compare the age group 75 to 84 and 85 to 99 to see if physical and mental performance as well as quality of life will improve., conditionsModule conditions: Activity, Motor, conditions: Elderly Patients, conditions: Musculoskeletal Diseases, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: RETROSPECTIVE, enrollmentInfo count: 2270, type: ACTUAL, armsInterventionsModule interventions name: inpatient rehabilitation, outcomesModule primaryOutcomes measure: FIM, primaryOutcomes measure: TUG, primaryOutcomes measure: EQ-5D (Quality of life), primaryOutcomes measure: PROMIS, eligibilityModule sex: ALL, minimumAge: 75 Years, maximumAge: 100 Years, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Klinik Valens, city: Valens, state: Saint Gallen, zip: CH-7317, country: Switzerland, geoPoint lat: 46.96658, lon: 9.47705, hasResults: False
protocolSection identificationModule nctId: NCT06307197, orgStudyIdInfo id: INRCA_008_2023, briefTitle: HAAL: HeAlthy Ageing Eco-system for peopLe With Dementia, acronym: HAAL, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-10-02, primaryCompletionDateStruct date: 2024-04-15, completionDateStruct date: 2024-04-15, studyFirstPostDateStruct date: 2024-03-12, lastUpdatePostDateStruct date: 2024-03-12, sponsorCollaboratorsModule leadSponsor name: Istituto Nazionale di Ricovero e Cura per Anziani, class: OTHER, descriptionModule briefSummary: HAAL project aims to test several technological devices in order to improve the quality of life of older people with dementia and their informal and formal caregiver., conditionsModule conditions: Dementia, conditions: Devices, conditions: Artificial Intelligence, conditions: Older People, conditions: Caregiver Burden, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: OTHER, maskingInfo masking: NONE, enrollmentInfo count: 10, type: ESTIMATED, armsInterventionsModule interventions name: HAAL platform, outcomesModule primaryOutcomes measure: Care load of caregivers, eligibilityModule sex: ALL, minimumAge: 65 Years, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: IRCCS INRCA Hospital, status: RECRUITING, city: Ancona, country: Italy, contacts name: Elvira Maranesi, role: CONTACT, email: e.maranesi@inrca.it, contacts name: Roberta Bevilacqua, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 43.5942, lon: 13.50337, hasResults: False
protocolSection identificationModule nctId: NCT06307184, orgStudyIdInfo id: 2301-LIS-007-AN, briefTitle: Assessing the Convenience of Natural Proliferative Phase Frozen Embryo Transfer, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-02-23, primaryCompletionDateStruct date: 2024-10, completionDateStruct date: 2025-07, studyFirstPostDateStruct date: 2024-03-12, lastUpdatePostDateStruct date: 2024-03-12, sponsorCollaboratorsModule leadSponsor name: Instituto Valenciano de Infertilidade de Lisboa, class: NETWORK, collaborators name: Gedeon Richter Ltd., descriptionModule briefSummary: This study will assess the convenience of the natural proliferative phase frozen embryo transfer (NPP-FET) in terms of number of number of appointments needed before cycle scheduling., conditionsModule conditions: Frozen Embryo Transfer, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: OTHER, enrollmentInfo count: 530, type: ESTIMATED, armsInterventionsModule interventions name: Natural proliferative phase frozen embryo transfer, outcomesModule primaryOutcomes measure: Number of appointments needed before cycle scheduling, secondaryOutcomes measure: Cycle duration until embryo transfer (days), secondaryOutcomes measure: Proportion of patients with low progesterone values on the day of embryo transfer, secondaryOutcomes measure: Human corionic gonadotropin (hCG) positive rate, secondaryOutcomes measure: Miscarriage rate, secondaryOutcomes measure: Ongoing pregnancy rate, secondaryOutcomes measure: Live birth rate, otherOutcomes measure: Serum Relaxin-2 levels, otherOutcomes measure: Serum Luteinizing Hormone (LH) levels, eligibilityModule sex: FEMALE, minimumAge: 18 Years, maximumAge: 49 Years, stdAges: ADULT, contactsLocationsModule locations facility: Instituto Valenciano de Infertilidade, status: RECRUITING, city: Lisboa, country: Portugal, contacts name: Samuel Santos-Ribeiro, MD PhD, role: CONTACT, geoPoint lat: 38.71667, lon: -9.13333, hasResults: False